Chronic cough, defined as a persistent cough lasting over eight weeks, poses a significant diagnostic challenge to clinicians. It often results in substantial patient distress and impaired quality of life. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Diagnosis of chronic cough involves a thorough history taking and physical examination to identify potential causes. An understanding of the cough reflex and the concept of cough hypersensitivity syndrome is crucial. The patient's exposure history, associated symptoms, and response to previous treatments provide valuable clues. Investigations including chest radiography, spirometry, and when indicated, bronchoscopy or CT scan should be considered.
Management of chronic cough should be tailored according to the underlying cause. Empiric treatment trials targeting the most common causes - gastroesophageal reflux disease (GERD), upper airway cough syndrome (UACS), and asthma - can be considered in the absence of specific diagnostic clues. Non-pharmacological approaches including speech therapy and behavioral modification have shown promising results.
Emerging therapies targeting neural pathways involved in cough reflex are under investigation. Drugs like P2X3 receptor antagonists have shown potential in reducing cough frequency in patients with refractory chronic cough. However, more extensive studies are needed to establish their safety and efficacy.
Chronic cough represents a complex interplay of various factors leading to cough hypersensitivity. A structured, patient-centered approach is required for effective management. While empiric treatments remain the mainstay, emerging therapies offer hope for patients with refractory chronic cough. Continuous research and clinical trials are essential to further our understanding and management of this challenging condition.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation